EligibleTrials

Effects of Exogenous Ketosis on Proteinuria and Renal Function

Recruiting · NCT06867471 · Interventional (participants receive a specific treatment) · Lead sponsor: Gødstrup Hospital

View the official record on ClinicalTrials.gov →
Chronic kidney disease

Interventions studied

Ketone Diol, R-1,3-butanediol (Ketone-IQ)Placebo drink

What this trial is about

A randomized, placebo-controlled, double-blinded crossover study will be conducted. Fourteen patients with polycystic kidney disease (PKD) and 29 patients with proteinuric kidney disease will receive ketone bodies (Ketone-IQ) and placebo in a randomized order. Each treatment period is four weeks. There will be a wash-out period of two weeks in between treatment periods. Effect variables will be measured in the last day of each treatment period.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.